Information Provided By: 
Fly News Breaks for October 13, 2017
NSRGY, CDXS
Oct 13, 2017 | 08:13 EDT
Craig-Hallum analyst Matt Hewitt says Codexis (CDXS) has a "unique proprietary CodeEvolver protein engineering platform" that is being sought by large pharma names, citing yesterday's announcement of a partnership with Nestle (NSRGY). Hewitt says that despite the recent stock price appreciation, the increasing value of the company's development pipeline suggests the markets is just starting to recognize the opportunity. The analyst has a Buy rating and a $7 price target on the stock.
News For CDXS;NSRGY From the Last 2 Days
There are no results for your query CDXS;NSRGY
